PNC Financial Services Group’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
PNC Financial Services Group's CLPT Position: Q3 2026 in Review
PNC Financial Services Group increased its ClearPoint Neuro (CLPT) stake by 2.8% in Q3 2026, buying an estimated $1.67K and bringing the position to 4,111 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3381.
PNC Financial Services Group first reported a position in CLPT in Q1 2021 and has held it in 10 quarters since. The position peaked at $87.2K in Q3 2025. 124 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.
- PNC Financial Services Group held 4,111 shares of ClearPoint Neuro worth $50.2K as of Q3 2026.
- PNC Financial Services Group bought 111 ClearPoint Neuro shares in Q3 2026, an estimated $1.67K.
- ClearPoint Neuro made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3381 holding.
- PNC Financial Services Group first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 10 quarters since.
- PNC Financial Services Group's ClearPoint Neuro position peaked at $87.2K in Q3 2025.
- 124 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.